For decades, the public consciousness surrounding breast cancer has been defined by a singular, gendered image. Campaigns...
Rifan Muazin
In the quiet corridors of modern medicine, a transformation is underway that transcends traditional pharmacology. We are...
The 2026 edition of the ESMO Breast Cancer Congress has concluded, leaving behind a clear roadmap for...
Traumatic brain injury (TBI) is a silent global epidemic. Every year, an estimated 69 million individuals sustain...
In a landmark development for neurogenetics, a research team led by The Jackson Laboratory (JAX) and the...
In the high-stakes world of pharmaceutical development, where a single Phase 3 clinical trial can represent a...
The global trajectory toward achieving the United Nations’ health-related Sustainable Development Goals (SDGs) is at a critical,...
The landscape of breast cancer treatment is currently undergoing a paradigm shift, moving away from "one-size-fits-all" chemotherapy...
A revolutionary antiviral drug, Hepcludex (bulevirtide-gmod), has achieved a monumental victory in the fight against the Hepatitis...
In the landscape of oncology, few challenges are as persistent as the management of biochemically recurrent (BCR)...
